mCRC | Metastatic colorectal cancer |
CT | Chemotherapy |
B | Bevacizumab |
VEGF | Vascular endothelial growth factor |
eNOS | Endothelial nitric oxide synthase |
COX2 | Cyclooxygenase-2 |
EPHB4 | Ephrin type-B receptor 4 |
HIF-1 | Hypoxia-inducible factor 1 |
LDH | Lactate dehydrogenase |
hs-CRP | High-sensitivity C-reactive protein |
NLR | Neutrophil-lymphocyte ratio |
PLR | Platelet-lymphocyte ratio |
SII | Systemic immune-inflammation index |
PFS | Progression-free survival |
OS | Overall survival |